CASI PHARMACEUTICALS INC（CASIF.US）股東結構 - 機構持倉、大股東與內部人士｜長橋證券

© 2026 Longbridge｜服務條款隱私政策

股東類型

公眾及其他34.91%
創投/私募27.38%
個人與內幕人士20.93%
機構投資者12.36%
私人企業4.42%

主要股東

主要股東最新
股東
Panacea Venture Management Co., Ltd.	22.04%	453.00 萬	0.00%	+0	30/04/2026
Zhenfeng Chen	10.97%	225.56 萬	0.00%	+0	30/04/2026
Wei-Wu HeExecutive Chairman of the Board & Principal Executive Officer	9.78%	201.06 萬	0.00%	+0	18/05/2026
Emerging Technology Partners, LLC	5.34%	109.73 萬	0.00%	+0	18/05/2026
VR Management, LLC	4.80%	98.73 萬	0.00%	+0	30/04/2026
IDG Capital	4.46%	91.59 萬	0.00%	+0	30/09/2025
Wealth Strategy Holding Ltd	4.42%	90.88 萬	0.00%	+0	21/03/2025
Huiying Memorial Foundation	3.10%	63.76 萬	0.00%	+0	18/05/2026
Y. Alexander WuIndependent Director	0.17%	3.42 萬	0.00%	+0	30/04/2026
Wei ZhangFormer Senior Vice President	<0.01%	2,015.00	0.00%	+0	30/04/2026
West Paces Advisors, Inc.	<0.01%	100.00	--	+100.00	30/06/2026
Thomas FolinsbeeIndependent Director	0.00%	0.00	--	+0	30/04/2026
Hai HuangChief Commercial Officer & GM	0.00%	0.00	--	+0	30/04/2026
Wei GaoGeneral Counsel	0.00%	0.00	--	+0	30/04/2026
Xuebo ZengIndependent Director	0.00%	0.00	--	+0	30/04/2026
Chunhua WangChief Operating Officer	0.00%	0.00	--	+0	30/04/2026
Kun QianVP & Global Controller	0.00%	0.00	--	+0	30/04/2026
Zhenbo SuIndependent Director	0.00%	0.00	--	+0	30/04/2026
Simplex Trading, LLC	0.00%	0.00	<0.01%	-228.00	30/06/2026
Zuie-Chin HuangIndependent Director	0.00%	0.00	0.00%	+0	30/04/2026